These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 448936)

  • 1. Mexiletine. Use in control of chronic drug-resistant ventricular arrhythmia.
    Abinader EG; Cooper M
    JAMA; 1979 Jul; 242(4):337-9. PubMed ID: 448936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine. Long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias.
    Kerin NZ; Aragon E; Marinescu G; Faitel K; Frumin H; Rubenfire M
    Arch Intern Med; 1990 Feb; 150(2):381-4. PubMed ID: 2302013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
    Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P
    G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral mexiletine in the treatment of refractory ventricular arrhythmias: the role of electrophysiologic techniques.
    Schoenfeld MH; Whitford E; McGovern B; Garan H; Ruskin JN
    Am Heart J; 1984 May; 107(5 Pt 2):1071-8. PubMed ID: 6372423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
    Aguglia F; Gnecchi M; De Marzio P
    Int J Cardiol; 1985 Mar; 7(3):303-6. PubMed ID: 2579918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine and tocainide: does response to one predict response to the other?
    Hession M; Blum R; Podrid PJ; Lampert S; Stein J; Lown B
    J Am Coll Cardiol; 1986 Feb; 7(2):338-43. PubMed ID: 3080508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine in clinical practice.
    Boyle DM
    Acta Cardiol Suppl; 1980; (25):137-45. PubMed ID: 6990665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction.
    Campbell RW; Achuff SC; Pottage A; Murray A; Prescott LF; Julian DG
    J Cardiovasc Pharmacol; 1979; 1(1):43-52. PubMed ID: 94381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mexiletine in refractory ventricular arrhythmias.
    Fenster PE; Kern KB
    Clin Pharmacol Ther; 1983 Dec; 34(6):777-84. PubMed ID: 6641093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of mexiletine and propafenone by dynamic electrocardiography].
    Marzegalli M; Bernasconi M; Brambilla G; Micheletti T; Potenza S; Regalia F; Barbaresco L; Bossi M
    G Ital Cardiol; 1984 May; 14(5):352-6. PubMed ID: 6468816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.
    Koch G; Lindström B
    Eur J Clin Pharmacol; 1978 Jun; 13(4):237-40. PubMed ID: 352705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine for refractory-ventricular arrhythmias: results using serial electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1981 Jan; 47(1):131-8. PubMed ID: 7457398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias.
    Breithardt G; Seipel L; Lersmacher J; Abendroth RR
    J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812
    [No Abstract]   [Full Text] [Related]  

  • 18. Mexiletine vs. lignocaine in the management of ventricular arrhythmias after open-heart surgery.
    Bury RW; Hale G; Higginbotham M; Mashford ML; Zuidland P
    Med J Aust; 1982 Mar; 1(6):265-7. PubMed ID: 7045605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative anti-arrhythmic efficacy of mexiletine, procainamide and tolamolol in patients with symptomatic ventricular arrhythmias.
    Jewitt DE; Jackson G; McComish M
    Postgrad Med J; 1977; 53 Suppl 1():158-62. PubMed ID: 327454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.